ArticlePerioperative medicine (London, England)2025
Comparing fentanyl and dexmedetomidine as adjuvants to bupivacaine for spinal anesthesia in appendectomy: effects on peritoneal symptoms - a randomized clinical trial.
Article in Perioperative medicine (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPeritoneal symptoms, including visceral pain, abdominal discomfort, and vagal responses (e.g., nausea, bradycardia), are common during abdominal surgeries under spinal anesthesia. This study compared intrathecal dexmedetomidine and fentanyl for their effectiveness in controlling these symptoms during appendectomy.
methodsThis randomized, double-blinded clinical trial included 150 patients of the American Society of Anesthesiologists I, II physical status scheduled for emergency open appendectomy. Participants were randomly assigned to receive either intrathecal dexmedetomidine (5 μg, Group D) or fentanyl (25 μg, Group F), both combined with 0.5% hyperbaric bupivacaine.
resultsDexmedetomidine significantly reduced the incidence of peritoneal symptoms compared to fentanyl: abdominal discomfort (9.5% vs. 33.3%), visceral pain (10.8% vs. 53.3%), nausea (9.5% vs. 34.7%), and vomiting (6.8% vs.34.7%) (P < 0.001). The time to first rescue analgesia was significantly longer in the dexmedetomidine group (396 vs. 243 min; P < 0.001). Bradycardia was more frequent in group D (25.7% vs. 1.3%, P < .001); no cases of respiratory depression were observed. Hypotension occurred slightly more frequently in group D, whereas shivering was more prevalent in group F; however, neither difference reached statistical significance. The VAS was significantly higher in group F than in group D at four and six hours postoperatively (P < 0.001).
conclusionsDexmedetomidine provides superior peritoneal symptom control and prolonged analgesia compared to fentanyl as an intrathecal adjuvant in spinal anesthesia for appendectomy. Despite a higher incidence of bradycardia, its opioid-sparing benefits and overall safety make it a valuable alternative, particularly for procedures involving significant visceral manipulation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.